| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.976 | 0.001 | 0.976 | Androgen antagonist | 0.948 0.002 DBMET02891 0.948 0.002 DBMET02894 0.912 0.002 DBMET02892 0.912 0.002 DBMET02893 0.912 0.002 DBMET02895 0.912 0.002 DBMET02896 | ||
| 0.97 | 0.002 | 0.97 | Aldehyde oxidase inhibitor | 0.952 0.002 DBMET02891 0.952 0.002 DBMET02894 0.955 0.002 DBMET02892 0.955 0.002 DBMET02893 0.955 0.002 DBMET02895 0.955 0.002 DBMET02896 | ||
| 0.969 | 0.001 | 0.969 | Androgen agonist | 0.872 0.001 DBMET02891 0.872 0.001 DBMET02894 0.887 0.001 DBMET02892 0.887 0.001 DBMET02893 0.887 0.001 DBMET02895 0.887 0.001 DBMET02896 | ||
| 0.931 | 0 | 0.931 | Anabolic | 0.819 0.001 DBMET02891 0.819 0.001 DBMET02894 0.872 0 DBMET02892 0.872 0 DBMET02893 0.872 0 DBMET02895 0.872 0 DBMET02896 | ||
| 0.879 | 0.001 | 0.879 | Progesterone antagonist | 0.77 0.001 DBMET02891 0.77 0.001 DBMET02894 0.665 0.002 DBMET02892 0.665 0.002 DBMET02893 0.665 0.002 DBMET02895 0.665 0.002 DBMET02896 | ||
| 0.857 | 0.002 | 0.857 | Estrogen agonist | 0.833 0.002 DBMET02891 0.833 0.002 DBMET02894 0.833 0.002 DBMET02892 0.833 0.002 DBMET02893 0.833 0.002 DBMET02895 0.833 0.002 DBMET02896 | ||
| 0.827 | 0.002 | 0.827 | Aromatase inhibitor | 0.703 0.002 DBMET02891 0.703 0.002 DBMET02894 0.633 0.002 DBMET02892 0.633 0.002 DBMET02893 0.633 0.002 DBMET02895 0.633 0.002 DBMET02896 | ||
| 0.818 | 0.002 | 0.818 | Estrogen receptor alpha antagonist | 0.684 0.002 DBMET02891 0.684 0.002 DBMET02894 0.676 0.003 DBMET02892 0.676 0.003 DBMET02893 0.676 0.003 DBMET02895 0.676 0.003 DBMET02896 | ||
| 0.813 | 0.001 | 0.813 | Glucocorticoid antagonist | 0.724 0.001 DBMET02891 0.724 0.001 DBMET02894 0.676 0.001 DBMET02892 0.676 0.001 DBMET02893 0.676 0.001 DBMET02895 0.676 0.001 DBMET02896 | ||
| 0.795 | 0.016 | 0.85 | Antiinflammatory | 0.821 0.013 DBMET02891 0.821 0.013 DBMET02894 0.85 0.009 DBMET02892 0.85 0.009 DBMET02893 0.85 0.009 DBMET02895 0.85 0.009 DBMET02896 | DBMET02896 | |
| 0.761 | 0.003 | 0.761 | Estrogen antagonist | 0.712 0.003 DBMET02891 0.712 0.003 DBMET02894 0.67 0.003 DBMET02892 0.67 0.003 DBMET02893 0.67 0.003 DBMET02895 0.67 0.003 DBMET02896 | ||
| 0.749 | 0.004 | 0.749 | Hypoxia-inducible factor 1 alpha inhibitor | 0.611 0.007 DBMET02891 0.611 0.007 DBMET02894 0.633 0.006 DBMET02892 0.633 0.006 DBMET02893 0.633 0.006 DBMET02895 0.633 0.006 DBMET02896 | ||
| 0.744 | 0.017 | 0.751 | Transcription factor NF kappa B inhibitor | 0.747 0.016 DBMET02891 0.747 0.016 DBMET02894 0.751 0.016 DBMET02892 0.751 0.016 DBMET02893 0.751 0.016 DBMET02895 0.751 0.016 DBMET02896 | DBMET02896 | |
| 0.711 | 0.001 | 0.711 | Progesterone agonist | 0.572 0.001 DBMET02891 0.572 0.001 DBMET02894 0.492 0.001 DBMET02892 0.492 0.001 DBMET02893 0.492 0.001 DBMET02895 0.492 0.001 DBMET02896 | ||
| 0.704 | 0.001 | 0.704 | Lipocortins synthesis antagonist | 0.673 0.001 DBMET02891 0.673 0.001 DBMET02894 0.681 0.001 DBMET02892 0.681 0.001 DBMET02893 0.681 0.001 DBMET02895 0.681 0.001 DBMET02896 | ||
| 0.668 | 0.004 | 0.668 | Diuretic | 0.545 0.005 DBMET02891 0.545 0.005 DBMET02894 0.425 0.012 DBMET02892 0.425 0.012 DBMET02893 0.425 0.012 DBMET02895 0.425 0.012 DBMET02896 | ||
| 0.661 | 0.037 | 0.739 | Apoptosis agonist | 0.68 0.034 DBMET02891 0.68 0.034 DBMET02894 0.739 0.024 DBMET02892 0.739 0.024 DBMET02893 0.739 0.024 DBMET02895 0.739 0.024 DBMET02896 | DBMET02896 | |
| 0.615 | 0.002 | 0.615 | Mineralocorticoid receptor antagonist | 0.464 0.003 DBMET02891 0.464 0.003 DBMET02894 0.351 0.003 DBMET02892 0.351 0.003 DBMET02893 0.351 0.003 DBMET02895 0.351 0.003 DBMET02896 | ||
| 0.602 | 0.004 | 0.675 | Anesthetic general | 0.644 0.004 DBMET02891 0.644 0.004 DBMET02894 0.675 0.004 DBMET02892 0.675 0.004 DBMET02893 0.675 0.004 DBMET02895 0.675 0.004 DBMET02896 | DBMET02896 | |
| 0.58 | 0.001 | 0.58 | Aldosterone antagonist | 0.27 0.003 DBMET02891 0.27 0.003 DBMET02894 0.262 0.003 DBMET02892 0.262 0.003 DBMET02893 0.262 0.003 DBMET02895 0.262 0.003 DBMET02896 | ||
| 0.551 | 0.003 | 0.564 | Estrogen receptor beta antagonist | 0.564 0.003 DBMET02891 0.564 0.003 DBMET02894 0.491 0.004 DBMET02892 0.491 0.004 DBMET02893 0.491 0.004 DBMET02895 0.491 0.004 DBMET02896 | DBMET02894 | |
| 0.549 | 0.002 | 0.556 | Estrogen receptor alpha agonist | 0.552 0.002 DBMET02891 0.552 0.002 DBMET02894 0.556 0.002 DBMET02892 0.556 0.002 DBMET02893 0.556 0.002 DBMET02895 0.556 0.002 DBMET02896 | DBMET02896 | |
| 0.538 | 0.002 | 0.542 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.408 0.003 DBMET02891 0.408 0.003 DBMET02894 0.542 0.002 DBMET02892 0.542 0.002 DBMET02893 0.542 0.002 DBMET02895 0.542 0.002 DBMET02896 | DBMET02896 | |
| 0.55 | 0.021 | 0.608 | Immunosuppressant | 0.566 0.018 DBMET02891 0.566 0.018 DBMET02894 0.608 0.012 DBMET02892 0.608 0.012 DBMET02893 0.608 0.012 DBMET02895 0.608 0.012 DBMET02896 | DBMET02896 | |
| 0.523 | 0.003 | 0.56 | Sodium/bile acid cotransporter inhibitor | 0.517 0.003 DBMET02891 0.517 0.003 DBMET02894 0.56 0.002 DBMET02892 0.56 0.002 DBMET02893 0.56 0.002 DBMET02895 0.56 0.002 DBMET02896 | DBMET02896 | |
| 0.521 | 0.002 | 0.521 | Estradiol 17 beta-dehydrogenase inhibitor | 0.291 0.003 DBMET02891 0.291 0.003 DBMET02894 0.233 0.004 DBMET02892 0.233 0.004 DBMET02893 0.233 0.004 DBMET02895 0.233 0.004 DBMET02896 | ||
| 0.545 | 0.046 | 0.573 | Caspase 9 stimulant | 0.452 0.082 DBMET02891 0.452 0.082 DBMET02894 0.573 0.04 DBMET02892 0.573 0.04 DBMET02893 0.573 0.04 DBMET02895 0.573 0.04 DBMET02896 | DBMET02896 | |
| 0.492 | 0.034 | 0.675 | Cholesterol antagonist | 0.568 0.023 DBMET02891 0.568 0.023 DBMET02894 0.675 0.01 DBMET02892 0.675 0.01 DBMET02893 0.675 0.01 DBMET02895 0.675 0.01 DBMET02896 | DBMET02896 | |
| 0.452 | 0.003 | 0.452 | Estrogen receptor beta agonist | 0.446 0.003 DBMET02891 0.446 0.003 DBMET02894 0.397 0.003 DBMET02892 0.397 0.003 DBMET02893 0.397 0.003 DBMET02895 0.397 0.003 DBMET02896 | ||
| 0.409 | 0.025 | 0.441 | Nitric oxide antagonist | 0.411 0.024 DBMET02891 0.411 0.024 DBMET02894 0.441 0.021 DBMET02892 0.441 0.021 DBMET02893 0.441 0.021 DBMET02895 0.441 0.021 DBMET02896 | DBMET02896 | |
| 0.374 | 0.012 | 0.391 | Interferon gamma antagonist | 0.368 0.013 DBMET02891 0.368 0.013 DBMET02894 0.391 0.011 DBMET02892 0.391 0.011 DBMET02893 0.391 0.011 DBMET02895 0.391 0.011 DBMET02896 | DBMET02896 | |
| 0.352 | 0.002 | 0.352 | 5-Alpha-reductase inhibitor | 0.295 0.003 DBMET02891 0.295 0.003 DBMET02894 0.222 0.004 DBMET02892 0.222 0.004 DBMET02893 0.222 0.004 DBMET02895 0.222 0.004 DBMET02896 | ||
| 0.332 | 0.014 | 0.332 | NOS3 expression enhancer | 0.163 0.061 DBMET02891 0.163 0.061 DBMET02894 0.235 0.03 DBMET02892 0.235 0.03 DBMET02893 0.235 0.03 DBMET02895 0.235 0.03 DBMET02896 | ||
| 0.328 | 0.015 | 0.328 | Lipid peroxidase inhibitor | 0.245 0.028 DBMET02891 0.245 0.028 DBMET02894 0.26 0.025 DBMET02892 0.26 0.025 DBMET02893 0.26 0.025 DBMET02895 0.26 0.025 DBMET02896 | ||
| 0.31 | 0.002 | 0.401 | RNA-directed RNA polymerase stimulant | 0.401 0.001 DBMET02891 0.401 0.001 DBMET02894 0.337 0.002 DBMET02892 0.337 0.002 DBMET02893 0.337 0.002 DBMET02895 0.337 0.002 DBMET02896 | DBMET02894 | |
| 0.306 | 0.002 | 0.307 | Arachidonic acid antagonist | 0.307 0.002 DBMET02891 0.307 0.002 DBMET02894 0.293 0.002 DBMET02892 0.293 0.002 DBMET02893 0.293 0.002 DBMET02895 0.293 0.002 DBMET02896 | DBMET02894 | |
| 0.316 | 0.015 | 0.316 | Bone formation stimulant | 0.291 0.018 DBMET02891 0.291 0.018 DBMET02894 0.281 0.019 DBMET02892 0.281 0.019 DBMET02893 0.281 0.019 DBMET02895 0.281 0.019 DBMET02896 | ||
| 0.302 | 0.002 | 0.302 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.16 0.003 DBMET02891 0.16 0.003 DBMET02894 0.165 0.003 DBMET02892 0.165 0.003 DBMET02893 0.165 0.003 DBMET02895 0.165 0.003 DBMET02896 | ||
| 0.316 | 0.016 | 0.316 | Monophenol monooxygenase inhibitor | 0.27 0.021 DBMET02891 0.27 0.021 DBMET02894 0.228 0.027 DBMET02892 0.228 0.027 DBMET02893 0.228 0.027 DBMET02895 0.228 0.027 DBMET02896 | ||
| 0.301 | 0.023 | 0.301 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.294 0.025 DBMET02891 0.294 0.025 DBMET02894 0.274 0.032 DBMET02892 0.274 0.032 DBMET02893 0.274 0.032 DBMET02895 0.274 0.032 DBMET02896 | ||
| 0.323 | 0.049 | 0.323 | DNA damaging | 0.292 0.06 DBMET02891 0.292 0.06 DBMET02894 0.3 0.057 DBMET02892 0.3 0.057 DBMET02893 0.3 0.057 DBMET02895 0.3 0.057 DBMET02896 | ||
| 0.268 | 0.004 | 0.276 | Prolactin inhibitor | 0.261 0.004 DBMET02891 0.261 0.004 DBMET02894 0.276 0.004 DBMET02892 0.276 0.004 DBMET02893 0.276 0.004 DBMET02895 0.276 0.004 DBMET02896 | DBMET02896 | |
| 0.267 | 0.02 | 0.282 | Antipruritic | 0.282 0.017 DBMET02891 0.282 0.017 DBMET02894 0.268 0.02 DBMET02892 0.268 0.02 DBMET02893 0.268 0.02 DBMET02895 0.268 0.02 DBMET02896 | DBMET02894 | |
| 0.244 | 0.005 | 0.244 | Keratolytic | 0.18 0.01 DBMET02891 0.18 0.01 DBMET02894 0.194 0.009 DBMET02892 0.194 0.009 DBMET02893 0.194 0.009 DBMET02895 0.194 0.009 DBMET02896 | ||
| 0.264 | 0.031 | 0.33 | Neurotrophic factor enhancer | 0.33 0.012 DBMET02891 0.33 0.012 DBMET02894 0.317 0.014 DBMET02892 0.317 0.014 DBMET02893 0.317 0.014 DBMET02895 0.317 0.014 DBMET02896 | DBMET02894 | |
| 0.304 | 0.083 | 0.365 | Apoptosis antagonist | 0.265 0.113 DBMET02891 0.265 0.113 DBMET02894 0.365 0.049 DBMET02892 0.365 0.049 DBMET02893 0.365 0.049 DBMET02895 0.365 0.049 DBMET02896 | DBMET02896 | |
| 0.275 | 0.053 | 0.408 | DNA synthesis inhibitor | 0.311 0.04 DBMET02891 0.311 0.04 DBMET02894 0.408 0.02 DBMET02892 0.408 0.02 DBMET02893 0.408 0.02 DBMET02895 0.408 0.02 DBMET02896 | DBMET02896 | |
| 0.215 | 0.001 | 0.215 | Progesterone receptor A antagonist | 0.076 0.002 DBMET02891 0.076 0.002 DBMET02894 0.043 0.002 DBMET02892 0.043 0.002 DBMET02893 0.043 0.002 DBMET02895 0.043 0.002 DBMET02896 | ||
| 0.288 | 0.083 | 0.374 | Interleukin 2 agonist | 0.307 0.069 DBMET02891 0.307 0.069 DBMET02894 0.374 0.036 DBMET02892 0.374 0.036 DBMET02893 0.374 0.036 DBMET02895 0.374 0.036 DBMET02896 | DBMET02896 | |
| 0.21 | 0.01 | 0.21 | Interleukin 8 antagonist | 0.21 0.01 DBMET02891 0.21 0.01 DBMET02894 0.177 0.02 DBMET02892 0.177 0.02 DBMET02893 0.177 0.02 DBMET02895 0.177 0.02 DBMET02896 | ||
| 0.244 | 0.045 | 0.347 | Non-steroidal antiinflammatory agent | 0.347 0.02 DBMET02891 0.347 0.02 DBMET02894 0.296 0.029 DBMET02892 0.296 0.029 DBMET02893 0.296 0.029 DBMET02895 0.296 0.029 DBMET02896 | DBMET02894 | |
| 0.229 | 0.031 | 0.306 | Acetylcholine M1 receptor antagonist | 0.227 0.032 DBMET02891 0.227 0.032 DBMET02894 0.306 0.013 DBMET02892 0.306 0.013 DBMET02893 0.306 0.013 DBMET02895 0.306 0.013 DBMET02896 | DBMET02896 | |
| 0.201 | 0.003 | 0.201 | 5-Alpha-reductase 2 inhibitor | 0.139 0.004 DBMET02891 0.139 0.004 DBMET02894 0.046 0.007 DBMET02892 0.046 0.007 DBMET02893 0.046 0.007 DBMET02895 0.046 0.007 DBMET02896 | ||
| 0.24 | 0.045 | 0.286 | P-glycoprotein inhibitor | 0.27 0.036 DBMET02891 0.27 0.036 DBMET02894 0.286 0.032 DBMET02892 0.286 0.032 DBMET02893 0.286 0.032 DBMET02895 0.286 0.032 DBMET02896 | DBMET02896 | |
| 0.197 | 0.002 | 0.197 | Estrone sulfatase inhibitor | 0.187 0.002 DBMET02891 0.187 0.002 DBMET02894 0.177 0.003 DBMET02892 0.177 0.003 DBMET02893 0.177 0.003 DBMET02895 0.177 0.003 DBMET02896 | ||
| 0.196 | 0.003 | 0.196 | 5-Alpha-reductase 1 inhibitor | 0.115 0.004 DBMET02891 0.115 0.004 DBMET02894 0.025 0.01 DBMET02892 0.025 0.01 DBMET02893 0.025 0.01 DBMET02895 0.025 0.01 DBMET02896 | ||
| 0.226 | 0.052 | 0.335 | Hepatoprotectant | 0.283 0.035 DBMET02891 0.283 0.035 DBMET02894 0.335 0.022 DBMET02892 0.335 0.022 DBMET02893 0.335 0.022 DBMET02895 0.335 0.022 DBMET02896 | DBMET02896 | |
| 0.183 | 0.017 | 0.193 | Pregnane X receptor agonist | 0.187 0.015 DBMET02891 0.187 0.015 DBMET02894 0.193 0.013 DBMET02892 0.193 0.013 DBMET02893 0.193 0.013 DBMET02895 0.193 0.013 DBMET02896 | DBMET02896 | |
| 0.25 | 0.084 | 0.275 | Antioxidant | 0.222 0.1 DBMET02891 0.222 0.1 DBMET02894 0.275 0.072 DBMET02892 0.275 0.072 DBMET02893 0.275 0.072 DBMET02895 0.275 0.072 DBMET02896 | DBMET02896 | |
| 0.189 | 0.025 | 0.263 | Farnesoid X receptor antagonist | 0.181 0.029 DBMET02891 0.181 0.029 DBMET02894 0.263 0.01 DBMET02892 0.263 0.01 DBMET02893 0.263 0.01 DBMET02895 0.263 0.01 DBMET02896 | DBMET02896 | |
| 0.165 | 0.002 | 0.174 | Glucocorticoid agonist | 0.174 0.002 DBMET02891 0.174 0.002 DBMET02894 0.174 0.002 DBMET02892 0.174 0.002 DBMET02893 0.174 0.002 DBMET02895 0.174 0.002 DBMET02896 | DBMET02896 | |
| 0.159 | 0.006 | 0.192 | Glycine receptor antagonist | 0.142 0.009 DBMET02891 0.142 0.009 DBMET02894 0.192 0.004 DBMET02892 0.192 0.004 DBMET02893 0.192 0.004 DBMET02895 0.192 0.004 DBMET02896 | DBMET02896 | |
| 0.165 | 0.013 | 0.165 | Inducible nitric-oxide synthase inhibitor | 0.129 0.022 DBMET02891 0.129 0.022 DBMET02894 0.105 0.033 DBMET02892 0.105 0.033 DBMET02893 0.105 0.033 DBMET02895 0.105 0.033 DBMET02896 | ||
| 0.182 | 0.032 | 0.357 | Cholesterol synthesis inhibitor | 0.258 0.017 DBMET02891 0.258 0.017 DBMET02894 0.357 0.006 DBMET02892 0.357 0.006 DBMET02893 0.357 0.006 DBMET02895 0.357 0.006 DBMET02896 | DBMET02896 | |
| 0.18 | 0.033 | 0.189 | Alkylator | 0.114 0.074 DBMET02891 0.114 0.074 DBMET02894 0.189 0.029 DBMET02892 0.189 0.029 DBMET02893 0.189 0.029 DBMET02895 0.189 0.029 DBMET02896 | DBMET02896 | |
| 0.143 | 0.002 | 0.149 | Lipocortins synthesis agonist | 0.149 0.002 DBMET02891 0.149 0.002 DBMET02894 0.145 0.002 DBMET02892 0.145 0.002 DBMET02893 0.145 0.002 DBMET02895 0.145 0.002 DBMET02896 | DBMET02894 | |
| 0.142 | 0.005 | 0.142 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.085 0.014 DBMET02891 0.085 0.014 DBMET02894 0.07 0.021 DBMET02892 0.07 0.021 DBMET02893 0.07 0.021 DBMET02895 0.07 0.021 DBMET02896 | ||
| 0.182 | 0.05 | 0.182 | Melanin inhibitor | 0.149 0.082 DBMET02891 0.149 0.082 DBMET02894 0.15 0.081 DBMET02892 0.15 0.081 DBMET02893 0.15 0.081 DBMET02895 0.15 0.081 DBMET02896 | ||
| 0.163 | 0.031 | 0.23 | Microtubule formation inhibitor | 0.189 0.022 DBMET02891 0.189 0.022 DBMET02894 0.23 0.014 DBMET02892 0.23 0.014 DBMET02893 0.23 0.014 DBMET02895 0.23 0.014 DBMET02896 | DBMET02896 | |
| 0.183 | 0.052 | 0.22 | Interleukin 6 antagonist | 0.178 0.056 DBMET02891 0.178 0.056 DBMET02894 0.22 0.031 DBMET02892 0.22 0.031 DBMET02893 0.22 0.031 DBMET02895 0.22 0.031 DBMET02896 | DBMET02896 | |
| 0.136 | 0.009 | 0.24 | Glycine receptor agonist | 0.126 0.011 DBMET02891 0.126 0.011 DBMET02894 0.24 0.003 DBMET02892 0.24 0.003 DBMET02893 0.24 0.003 DBMET02895 0.24 0.003 DBMET02896 | DBMET02896 | |
| 0.14 | 0.015 | 0.14 | Ornithine decarboxylase inhibitor | 0.132 0.018 DBMET02891 0.132 0.018 DBMET02894 0.115 0.029 DBMET02892 0.115 0.029 DBMET02893 0.115 0.029 DBMET02895 0.115 0.029 DBMET02896 | ||
| 0.127 | 0.013 | 0.16 | Na+ K+ transporting ATPase inhibitor | 0.147 0.006 DBMET02891 0.147 0.006 DBMET02894 0.16 0.004 DBMET02892 0.16 0.004 DBMET02893 0.16 0.004 DBMET02895 0.16 0.004 DBMET02896 | DBMET02896 | |
| 0.206 | 0.092 | 0.221 | RNA-directed DNA polymerase inhibitor | 0.221 0.073 DBMET02891 0.221 0.073 DBMET02894 0.221 0.073 DBMET02892 0.221 0.073 DBMET02893 0.221 0.073 DBMET02895 0.221 0.073 DBMET02896 | DBMET02896 | |
| 0.16 | 0.047 | 0.256 | Cholinergic antagonist | 0.167 0.044 DBMET02891 0.167 0.044 DBMET02894 0.256 0.02 DBMET02892 0.256 0.02 DBMET02893 0.256 0.02 DBMET02895 0.256 0.02 DBMET02896 | DBMET02896 | |
| 0.157 | 0.047 | 0.253 | Acetylcholine antagonist | 0.165 0.043 DBMET02891 0.165 0.043 DBMET02894 0.253 0.02 DBMET02892 0.253 0.02 DBMET02893 0.253 0.02 DBMET02895 0.253 0.02 DBMET02896 | DBMET02896 | |
| 0.153 | 0.048 | 0.219 | DNA polymerase I inhibitor | 0.167 0.04 DBMET02891 0.167 0.04 DBMET02894 0.219 0.023 DBMET02892 0.219 0.023 DBMET02893 0.219 0.023 DBMET02895 0.219 0.023 DBMET02896 | DBMET02896 | |
| 0.108 | 0.014 | 0.326 | GABA receptor antagonist | 0.316 0.004 DBMET02891 0.316 0.004 DBMET02894 0.326 0.004 DBMET02892 0.326 0.004 DBMET02893 0.326 0.004 DBMET02895 0.326 0.004 DBMET02896 | DBMET02896 | |
| 0.095 | 0.002 | 0.095 | Corticosteroid-like | 0.087 0.002 DBMET02891 0.087 0.002 DBMET02894 0.089 0.002 DBMET02892 0.089 0.002 DBMET02893 0.089 0.002 DBMET02895 0.089 0.002 DBMET02896 | ||
| 0.107 | 0.014 | 0.295 | GABA A receptor antagonist | 0.289 0.004 DBMET02891 0.289 0.004 DBMET02894 0.295 0.004 DBMET02892 0.295 0.004 DBMET02893 0.295 0.004 DBMET02895 0.295 0.004 DBMET02896 | DBMET02896 | |
| 0.123 | 0.036 | 0.195 | Antineoplastic alkaloid | 0.195 0.015 DBMET02891 0.195 0.015 DBMET02894 0.174 0.021 DBMET02892 0.174 0.021 DBMET02893 0.174 0.021 DBMET02895 0.174 0.021 DBMET02896 | DBMET02894 | |
| 0.09 | 0.01 | 0.09 | Heme oxygenase stimulant | 0.088 0.011 DBMET02891 0.088 0.011 DBMET02894 0.078 0.017 DBMET02892 0.078 0.017 DBMET02893 0.078 0.017 DBMET02895 0.078 0.017 DBMET02896 | ||
| 0.079 | 0.004 | 0.123 | Glucose-6-phosphate dehydrogenase inhibitor | 0.091 0.003 DBMET02891 0.091 0.003 DBMET02894 0.123 0.002 DBMET02892 0.123 0.002 DBMET02893 0.123 0.002 DBMET02895 0.123 0.002 DBMET02896 | DBMET02896 | |
| 0.107 | 0.035 | 0.144 | Acetylcholine nicotinic antagonist | 0.095 0.043 DBMET02891 0.095 0.043 DBMET02894 0.144 0.022 DBMET02892 0.144 0.022 DBMET02893 0.144 0.022 DBMET02895 0.144 0.022 DBMET02896 | DBMET02896 | |
| 0.112 | 0.041 | 0.164 | Antineoplastic antibiotic | 0.126 0.037 DBMET02891 0.126 0.037 DBMET02894 0.164 0.028 DBMET02892 0.164 0.028 DBMET02893 0.164 0.028 DBMET02895 0.164 0.028 DBMET02896 | DBMET02896 | |
| 0.123 | 0.054 | 0.217 | GABA receptor agonist | 0.217 0.014 DBMET02891 0.217 0.014 DBMET02894 0.206 0.016 DBMET02892 0.206 0.016 DBMET02893 0.206 0.016 DBMET02895 0.206 0.016 DBMET02896 | DBMET02894 | |
| 0.077 | 0.008 | 0.079 | Pregnane X receptor antagonist | 0.079 0.007 DBMET02891 0.079 0.007 DBMET02894 0.069 0.015 DBMET02892 0.069 0.015 DBMET02893 0.069 0.015 DBMET02895 0.069 0.015 DBMET02896 | DBMET02894 | |
| 0.104 | 0.04 | 0.129 | Bile acid receptor antagonist | 0.096 0.057 DBMET02891 0.096 0.057 DBMET02894 0.129 0.013 DBMET02892 0.129 0.013 DBMET02893 0.129 0.013 DBMET02895 0.129 0.013 DBMET02896 | DBMET02896 | |
| 0.084 | 0.024 | 0.104 | Adrenaline uptake inhibitor | 0.075 0.03 DBMET02891 0.075 0.03 DBMET02894 0.104 0.018 DBMET02892 0.104 0.018 DBMET02893 0.104 0.018 DBMET02895 0.104 0.018 DBMET02896 | DBMET02896 | |
| 0.075 | 0.016 | 0.106 | Acetylcholine M2 receptor agonist | 0.086 0.01 DBMET02891 0.086 0.01 DBMET02894 0.106 0.006 DBMET02892 0.106 0.006 DBMET02893 0.106 0.006 DBMET02895 0.106 0.006 DBMET02896 | DBMET02896 | |
| 0.097 | 0.04 | 0.185 | GABA A receptor agonist | 0.185 0.011 DBMET02891 0.185 0.011 DBMET02894 0.168 0.013 DBMET02892 0.168 0.013 DBMET02893 0.168 0.013 DBMET02895 0.168 0.013 DBMET02896 | DBMET02894 | |
| 0.057 | 0.001 | 0.057 | Transcortin receptor antagonist | 0.028 0.001 DBMET02891 0.028 0.001 DBMET02894 0.032 0.001 DBMET02892 0.032 0.001 DBMET02893 0.032 0.001 DBMET02895 0.032 0.001 DBMET02896 | ||
| 0.167 | 0.112 | 0.264 | Angiogenesis stimulant | 0.264 0.064 DBMET02892 0.264 0.064 DBMET02893 0.264 0.064 DBMET02895 0.264 0.064 DBMET02896 | DBMET02896 | |
| 0.091 | 0.039 | 0.091 | Estrogen-related receptor beta agonist | 0.079 0.069 DBMET02891 0.079 0.069 DBMET02894 0.088 0.046 DBMET02892 0.088 0.046 DBMET02893 0.088 0.046 DBMET02895 0.088 0.046 DBMET02896 | ||
| 0.118 | 0.069 | 0.197 | Acetylcholine muscarinic antagonist | 0.135 0.054 DBMET02891 0.135 0.054 DBMET02894 0.197 0.025 DBMET02892 0.197 0.025 DBMET02893 0.197 0.025 DBMET02895 0.197 0.025 DBMET02896 | DBMET02896 | |
| 0.079 | 0.03 | 0.079 | Beta tubulin antagonist | |||
| 0.108 | 0.058 | 0.134 | Toll-Like receptor 4 antagonist | 0.108 0.057 DBMET02891 0.108 0.057 DBMET02894 0.134 0.031 DBMET02892 0.134 0.031 DBMET02893 0.134 0.031 DBMET02895 0.134 0.031 DBMET02896 | DBMET02896 | |
| 0.051 | 0.003 | 0.051 | Progesterone receptor B antagonist | 0.037 0.004 DBMET02891 0.037 0.004 DBMET02894 0.032 0.005 DBMET02892 0.032 0.005 DBMET02893 0.032 0.005 DBMET02895 0.032 0.005 DBMET02896 | ||
| 0.052 | 0.005 | 0.052 | Estrogen-related receptor beta antagonist | 0.043 0.008 DBMET02891 0.043 0.008 DBMET02894 0.046 0.007 DBMET02892 0.046 0.007 DBMET02893 0.046 0.007 DBMET02895 0.046 0.007 DBMET02896 | ||
| 0.07 | 0.024 | 0.07 | Alpha tubulin antagonist | 0.052 0.038 DBMET02891 0.052 0.038 DBMET02894 0.047 0.045 DBMET02892 0.047 0.045 DBMET02893 0.047 0.045 DBMET02895 0.047 0.045 DBMET02896 | ||
| 0.133 | 0.094 | 0.179 | Adenylate cyclase stimulant | 0.136 0.088 DBMET02891 0.136 0.088 DBMET02894 0.179 0.026 DBMET02892 0.179 0.026 DBMET02893 0.179 0.026 DBMET02895 0.179 0.026 DBMET02896 | DBMET02896 | |
| 0.125 | 0.091 | 0.132 | CC chemokine 6 receptor antagonist | 0.132 0.064 DBMET02891 0.132 0.064 DBMET02894 0.124 0.095 DBMET02892 0.124 0.095 DBMET02893 0.124 0.095 DBMET02895 0.124 0.095 DBMET02896 | DBMET02894 | |
| 0.042 | 0.008 | 0.042 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.029 0.012 DBMET02891 0.029 0.012 DBMET02894 | ||
| 0.047 | 0.018 | 0.054 | GABA uptake inhibitor | 0.054 0.013 DBMET02891 0.054 0.013 DBMET02894 0.045 0.02 DBMET02892 0.045 0.02 DBMET02893 0.045 0.02 DBMET02895 0.045 0.02 DBMET02896 | DBMET02894 | |
| 0.032 | 0.005 | 0.032 | Thyroid hormone alpha antagonist | 0.025 0.006 DBMET02891 0.025 0.006 DBMET02894 0.024 0.006 DBMET02892 0.024 0.006 DBMET02893 0.024 0.006 DBMET02895 0.024 0.006 DBMET02896 | ||
| 0.132 | 0.108 | 0.151 | Ca2+-transporting ATPase inhibitor | 0.142 0.067 DBMET02891 0.142 0.067 DBMET02894 0.151 0.04 DBMET02892 0.151 0.04 DBMET02893 0.151 0.04 DBMET02895 0.151 0.04 DBMET02896 | DBMET02896 | |
| 0.022 | 0.003 | 0.022 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | 0.019 0.003 DBMET02891 0.019 0.003 DBMET02894 0.014 0.006 DBMET02892 0.014 0.006 DBMET02893 0.014 0.006 DBMET02895 0.014 0.006 DBMET02896 | ||
| 0.038 | 0.02 | 0.048 | RNA-directed RNA polymerase inhibitor | 0.048 0.014 DBMET02891 0.048 0.014 DBMET02894 | DBMET02894 | |
| 0.023 | 0.005 | 0.061 | Vitamin D receptor agonist | 0.033 0.003 DBMET02891 0.033 0.003 DBMET02894 0.061 0.002 DBMET02892 0.061 0.002 DBMET02893 0.061 0.002 DBMET02895 0.061 0.002 DBMET02896 | DBMET02896 | |
| 0.029 | 0.015 | 0.076 | Hedgehog signaling activator | 0.035 0.006 DBMET02891 0.035 0.006 DBMET02894 0.076 0.002 DBMET02892 0.076 0.002 DBMET02893 0.076 0.002 DBMET02895 0.076 0.002 DBMET02896 | DBMET02896 | |
| 0.028 | 0.019 | 0.04 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.033 0.015 DBMET02891 0.033 0.015 DBMET02894 0.04 0.011 DBMET02892 0.04 0.011 DBMET02893 0.04 0.011 DBMET02895 0.04 0.011 DBMET02896 | DBMET02896 | |
| 0.136 | 0.129 | 0.191 | Psychostimulant | 0.191 0.085 DBMET02891 0.191 0.085 DBMET02894 0.159 0.108 DBMET02892 0.159 0.108 DBMET02893 0.159 0.108 DBMET02895 0.159 0.108 DBMET02896 | DBMET02894 | |
| 0.149 | 0.143 | 0.242 | Growth factor agonist | 0.242 0.035 DBMET02891 0.242 0.035 DBMET02894 0.158 0.123 DBMET02892 0.158 0.123 DBMET02893 0.158 0.123 DBMET02895 0.158 0.123 DBMET02896 | DBMET02894 | |
| 0.11 | 0.104 | 0.137 | Protein kinase stimulant | 0.137 0.078 DBMET02892 0.137 0.078 DBMET02893 0.137 0.078 DBMET02895 0.137 0.078 DBMET02896 | DBMET02896 | |
| 0.19 | 0.185 | 0.207 | Caspase 3 stimulant | 0.207 0.159 DBMET02892 0.207 0.159 DBMET02893 0.207 0.159 DBMET02895 0.207 0.159 DBMET02896 | DBMET02896 | |
| 0.073 | 0.071 | 0.12 | Opioid kappa receptor antagonist | 0.12 0.024 DBMET02891 0.12 0.024 DBMET02894 | DBMET02894 | |
| 0.015 | 0.016 | 0.028 | Telomerase stimulant | 0.02 0.008 DBMET02891 0.02 0.008 DBMET02894 0.028 0.003 DBMET02892 0.028 0.003 DBMET02893 0.028 0.003 DBMET02895 0.028 0.003 DBMET02896 | DBMET02896 | |
| 0.02 | 0.021 | 0.032 | Vitamin D receptor antagonist | 0.021 0.017 DBMET02891 0.021 0.017 DBMET02894 0.032 0.007 DBMET02892 0.032 0.007 DBMET02893 0.032 0.007 DBMET02895 0.032 0.007 DBMET02896 | DBMET02896 | |
| 0.036 | 0.05 | 0.055 | Microtubule stabilization | 0.047 0.032 DBMET02891 0.047 0.032 DBMET02894 0.055 0.021 DBMET02892 0.055 0.021 DBMET02893 0.055 0.021 DBMET02895 0.055 0.021 DBMET02896 | DBMET02896 | |
| 0.015 | 0.031 | 0.02 | Antibiotic Anthracycline-like | 0.018 0.016 DBMET02891 0.018 0.016 DBMET02894 0.02 0.01 DBMET02892 0.02 0.01 DBMET02893 0.02 0.01 DBMET02895 0.02 0.01 DBMET02896 | DBMET02896 | |
| 0.106 | 0.122 | 0.212 | Neurotrophic factor | 0.133 0.077 DBMET02891 0.133 0.077 DBMET02894 0.212 0.023 DBMET02892 0.212 0.023 DBMET02893 0.212 0.023 DBMET02895 0.212 0.023 DBMET02896 | DBMET02896 | |
| 0.038 | 0.057 | 0.066 | Parathyroid hormone antagonist | 0.066 0.008 DBMET02892 0.066 0.008 DBMET02893 0.066 0.008 DBMET02895 0.066 0.008 DBMET02896 | DBMET02896 | |
| 0.135 | 0.154 | 0.393 | Hypolipemic | 0.161 0.126 DBMET02891 0.161 0.126 DBMET02894 0.393 0.026 DBMET02892 0.393 0.026 DBMET02893 0.393 0.026 DBMET02895 0.393 0.026 DBMET02896 | DBMET02896 | |
| 0.131 | 0.152 | 0.259 | Phospholipase C inhibitor | 0.151 0.104 DBMET02891 0.151 0.104 DBMET02894 0.259 0.023 DBMET02892 0.259 0.023 DBMET02893 0.259 0.023 DBMET02895 0.259 0.023 DBMET02896 | DBMET02896 | |
| 0.033 | 0.056 | 0.045 | Potassium channel Kv1.3 blocker | 0.045 0.035 DBMET02891 0.045 0.035 DBMET02894 | DBMET02894 | |
| 0.015 | 0.042 | 0.022 | Protein 30S ribosomal subunit inhibitor | 0.022 0.019 DBMET02892 0.022 0.019 DBMET02893 0.022 0.019 DBMET02895 0.022 0.019 DBMET02896 | DBMET02896 | |
| 0.021 | 0.05 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.018 DBMET02892 0.027 0.018 DBMET02893 0.027 0.018 DBMET02895 0.027 0.018 DBMET02896 | DBMET02896 | |
| 0.022 | 0.053 | 0.085 | Farnesoid X receptor agonist | 0.085 0.005 DBMET02892 0.085 0.005 DBMET02893 0.085 0.005 DBMET02895 0.085 0.005 DBMET02896 | DBMET02896 | |
| 0.026 | 0.057 | 0.04 | Tubulin agonist | 0.033 0.026 DBMET02891 0.033 0.026 DBMET02894 0.04 0.015 DBMET02892 0.04 0.015 DBMET02893 0.04 0.015 DBMET02895 0.04 0.015 DBMET02896 | DBMET02896 | |
| 0.089 | 0.122 | 0.102 | Cyclooxygenase 3 inhibitor | 0.102 0.1 DBMET02892 0.102 0.1 DBMET02893 0.102 0.1 DBMET02895 0.102 0.1 DBMET02896 | DBMET02896 | |
| 0.069 | 0.103 | 0.096 | Transcription factor NF kappa B stimulant | 0.096 0.043 DBMET02892 0.096 0.043 DBMET02893 0.096 0.043 DBMET02895 0.096 0.043 DBMET02896 | DBMET02896 | |
| 0.024 | 0.067 | 0.065 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.056 0.025 DBMET02891 0.056 0.025 DBMET02894 0.065 0.021 DBMET02892 0.065 0.021 DBMET02893 0.065 0.021 DBMET02895 0.065 0.021 DBMET02896 | DBMET02896 | |
| 0.043 | 0.087 | 0.063 | Nitric oxide donor | 0.063 0.044 DBMET02892 0.063 0.044 DBMET02893 0.063 0.044 DBMET02895 0.063 0.044 DBMET02896 | DBMET02896 | |
| 0.034 | 0.079 | 0.078 | Dopamine uptake inhibitor | 0.078 0.026 DBMET02892 0.078 0.026 DBMET02893 0.078 0.026 DBMET02895 0.078 0.026 DBMET02896 | DBMET02896 | |
| 0.032 | 0.084 | 0.072 | Alcohol oxidase inhibitor | 0.07 0.029 DBMET02891 0.07 0.029 DBMET02894 0.072 0.028 DBMET02892 0.072 0.028 DBMET02893 0.072 0.028 DBMET02895 0.072 0.028 DBMET02896 | DBMET02896 | |
| 0.03 | 0.085 | 0.049 | GABA B receptor antagonist | 0.049 0.021 DBMET02892 0.049 0.021 DBMET02893 0.049 0.021 DBMET02895 0.049 0.021 DBMET02896 | DBMET02896 | |
| 0.019 | 0.077 | 0.046 | HMG CoA reductase inhibitor | 0.046 0.009 DBMET02892 0.046 0.009 DBMET02893 0.046 0.009 DBMET02895 0.046 0.009 DBMET02896 | DBMET02896 | |
| 0.066 | 0.134 | 0.1 | ABCA1 expression enhancer | 0.1 0.05 DBMET02892 0.1 0.05 DBMET02893 0.1 0.05 DBMET02895 0.1 0.05 DBMET02896 | DBMET02896 | |
| 0.021 | 0.09 | 0.039 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.039 0.023 DBMET02892 0.039 0.023 DBMET02893 0.039 0.023 DBMET02895 0.039 0.023 DBMET02896 | DBMET02896 | |
| 0.027 | 0.1 | 0.119 | Acetylcholine muscarinic agonist | 0.065 0.03 DBMET02891 0.065 0.03 DBMET02894 0.119 0.014 DBMET02892 0.119 0.014 DBMET02893 0.119 0.014 DBMET02895 0.119 0.014 DBMET02896 | DBMET02896 | |
| 0.049 | 0.14 | 0.079 | Opioid antagonist | 0.079 0.071 DBMET02891 0.079 0.071 DBMET02894 | DBMET02894 | |
| 0.018 | 0.109 | 0.038 | Opioid kappa receptor agonist | 0.038 0.037 DBMET02891 0.038 0.037 DBMET02894 | DBMET02894 | |
| 0.024 | 0.116 | 0.053 | Protein 50S ribosomal subunit inhibitor | 0.053 0.037 DBMET02892 0.053 0.037 DBMET02893 0.053 0.037 DBMET02895 0.053 0.037 DBMET02896 | DBMET02896 | |
| 0.025 | 0.122 | 0.104 | Acetylcholine M3 receptor antagonist | 0.104 0.017 DBMET02892 0.104 0.017 DBMET02893 0.104 0.017 DBMET02895 0.104 0.017 DBMET02896 | DBMET02896 | |
| 0.004 | 0.101 | 0.024 | Ileal bile acid transport inhibitor | 0.024 0.007 DBMET02892 0.024 0.007 DBMET02893 0.024 0.007 DBMET02895 0.024 0.007 DBMET02896 | DBMET02896 | |
| 0.15 | 0.251 | 0.324 | Antithrombotic | 0.219 0.155 DBMET02891 0.219 0.155 DBMET02894 0.324 0.075 DBMET02892 0.324 0.075 DBMET02893 0.324 0.075 DBMET02895 0.324 0.075 DBMET02896 | DBMET02896 | |
| 0.102 | 0.229 | 0.176 | Spasmolytic | 0.176 0.14 DBMET02892 0.176 0.14 DBMET02893 0.176 0.14 DBMET02895 0.176 0.14 DBMET02896 | DBMET02896 | |
| 0.092 | 0.237 | 0.242 | Immunostimulant | 0.242 0.1 DBMET02892 0.242 0.1 DBMET02893 0.242 0.1 DBMET02895 0.242 0.1 DBMET02896 | DBMET02896 | |
| 0.004 | 0.166 | 0.019 | Prostacyclin agonist | 0.019 0.009 DBMET02892 0.019 0.009 DBMET02893 0.019 0.009 DBMET02895 0.019 0.009 DBMET02896 | DBMET02896 | |
| 0.147 | 0.312 | 0.265 | Calcium channel activator | 0.265 0.13 DBMET02891 0.265 0.13 DBMET02894 0.257 0.139 DBMET02892 0.257 0.139 DBMET02893 0.257 0.139 DBMET02895 0.257 0.139 DBMET02896 | DBMET02894 | |
| 0.076 | 0.257 | 0.225 | Interleukin agonist | 0.225 0.098 DBMET02892 0.225 0.098 DBMET02893 0.225 0.098 DBMET02895 0.225 0.098 DBMET02896 | DBMET02896 | |
| 0.01 | 0.196 | 0.029 | Purinergic P2Y15 antagonist | 0.029 0.019 DBMET02892 0.029 0.019 DBMET02893 0.029 0.019 DBMET02895 0.029 0.019 DBMET02896 | DBMET02896 | |
| 0.134 | 0.326 | 0.238 | Antibacterial | 0.238 0.189 DBMET02892 0.238 0.189 DBMET02893 0.238 0.189 DBMET02895 0.238 0.189 DBMET02896 | DBMET02896 | |
| 0.044 | 0.255 | 0.104 | Mucolytic | 0.104 0.072 DBMET02892 0.104 0.072 DBMET02893 0.104 0.072 DBMET02895 0.104 0.072 DBMET02896 | DBMET02896 | |
| 0.032 | 0.254 | 0.094 | Expectorant | 0.094 0.075 DBMET02892 0.094 0.075 DBMET02893 0.094 0.075 DBMET02895 0.094 0.075 DBMET02896 | DBMET02896 | |
| 0.024 | 0.247 | 0.094 | Anesthetic local | 0.094 0.088 DBMET02892 0.094 0.088 DBMET02893 0.094 0.088 DBMET02895 0.094 0.088 DBMET02896 | DBMET02896 | |
| 0.028 | 0.256 | 0.116 | Acetylcholine M3 receptor agonist | 0.116 0.036 DBMET02892 0.116 0.036 DBMET02893 0.116 0.036 DBMET02895 0.116 0.036 DBMET02896 | DBMET02896 | |
| 0.024 | 0.265 | 0.081 | Acetylcholine agonist | 0.081 0.064 DBMET02892 0.081 0.064 DBMET02893 0.081 0.064 DBMET02895 0.081 0.064 DBMET02896 | DBMET02896 | |
| 0.042 | 0.289 | 0.103 | Alpha-N-acetylglucosaminidase inhibitor | 0.103 0.097 DBMET02892 0.103 0.097 DBMET02893 0.103 0.097 DBMET02895 0.103 0.097 DBMET02896 | DBMET02896 | |
| 0.078 | 0.339 | 0.191 | ATPase inhibitor | 0.191 0.046 DBMET02892 0.191 0.046 DBMET02893 0.191 0.046 DBMET02895 0.191 0.046 DBMET02896 | DBMET02896 | |
| 0.015 | 0.276 | 0.05 | Alpha-mannosidase inhibitor | 0.05 0.044 DBMET02892 0.05 0.044 DBMET02893 0.05 0.044 DBMET02895 0.05 0.044 DBMET02896 | DBMET02896 | |
| 0.117 | 0.382 | 0.234 | Analgesic | 0.234 0.198 DBMET02892 0.234 0.198 DBMET02893 0.234 0.198 DBMET02895 0.234 0.198 DBMET02896 | DBMET02896 | |
| 0.13 | 0.401 | 0.423 | Cyclophilin D inhibitor | 0.423 0.079 DBMET02892 0.423 0.079 DBMET02893 0.423 0.079 DBMET02895 0.423 0.079 DBMET02896 | DBMET02896 | |
| 0.091 | 0.388 | 0.345 | Immunomodulator | 0.345 0.061 DBMET02892 0.345 0.061 DBMET02893 0.345 0.061 DBMET02895 0.345 0.061 DBMET02896 | DBMET02896 | |
| 0.089 | 0.396 | 0.3 | Antiobesity | 0.3 0.116 DBMET02892 0.3 0.116 DBMET02893 0.3 0.116 DBMET02895 0.3 0.116 DBMET02896 | DBMET02896 | |
| 0.013 | 0.447 | 0.062 | Acetyl-CoA transferase 2 inhibitor | 0.062 0.028 DBMET02892 0.062 0.028 DBMET02893 0.062 0.028 DBMET02895 0.062 0.028 DBMET02896 | DBMET02896 | |
| 0.084 | 0.562 | 0.191 | Peptidyltransferase inhibitor | 0.191 0.111 DBMET02892 0.191 0.111 DBMET02893 0.191 0.111 DBMET02895 0.191 0.111 DBMET02896 | DBMET02896 | |
| 0.025 | 0.708 | 0.201 | Toll-Like receptor agonist | 0.201 0.2 DBMET02892 0.201 0.2 DBMET02893 0.201 0.2 DBMET02895 0.201 0.2 DBMET02896 | DBMET02896 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |